SDR42E1P2

Across TCGA pan-cancer cohorts, SDR42E1P2 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SDR42E1P2 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher SDR42E1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SDR42E1P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

LIHC, MESO, and OV are the cancer types where SDR42E1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.051	0.783	<.001	108	view →
MESO	DFS	Tertile	All	0.098	0.369	.004	54	view →
OV	OS	Tertile	II,III,IV	0.284	0.691	.034	54	view →
HNSC	OS	Tertile	II,III,IV	0.380	0.717	<.001	54	view →
BRCA	OS	Tertile	All	0.668	0.924	.018	36	view →
PCPG	DFS	Tertile	All	0.067	0.859	<.001	27	view →
LUSC	OS	Tertile	All	0.196	0.515	.024	24	view →
SKCM	DFS	Tertile	All	1.000	0.199	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

SDR42E1P2–LIHC (OS)

Open the LIHC breakdown →